AGM to be postponed
Faron Pharmaceuticals Oy ("Faron" or the "Company") AGM to be postponed Company announcement, 3 April 2020 at 4.45pm (EEST) TURKU, FINLAND - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today announces that, due to the prevailing Covid-19 situation, the Company's Board of Directors has decided to cancel the Company's annual general meeting ("AGM") scheduled to be held on 15 April 2020. A new notice will be published in due course to convene the AGM at a later stage. For more information please contact: